Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kei Ikeda

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Human Cell|June 23, 2022
Central nervous system stimulants promote nerve cell death under continuous hypoxiaKei Ikeda-Murakami, Tomoya Ikeda, Miho Watanabe, et al.
RSC Advances|July 22, 2022
Density functional theory analysis for H<sub>2</sub>S adsorption on pyridinic N- and oxidized N-doped graphenesTakaya Fujisaki, Kei Ikeda, Aleksandar Tsekov Staykov, et al.
International Journal of Molecular Sciences|February 15, 2022
Central Nervous System Stimulants Limit Caffeine Transport at the Blood-Cerebrospinal Fluid BarrierKei Ikeda-Murakami, Naoto Tani, Tomoya Ikeda, et al.
Modern Rheumatology|November 11, 2014
A long-term follow-up of Japanese mother and her daughter with Blau syndrome: Effective treatment of anti-TNF inhibitors and useful diagnostic tool of joint ultrasound examinationYoshikazu Otsubo, Ikuo Okafuji, Toshimasa Shimizu, et al.
International Journal of Rheumatic Diseases|August 7, 2023
Treatment pattern and changes in oral glucocorticoid dose after tocilizumab treatment in patients with adult Still's disease: An analysis of a Japanese claims databaseYuko Kaneko, Hideto Kameda, Kei Ikeda, et al.
Modern Rheumatology|October 29, 2022
Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: A population-based retrospective cohort studyKatsuhiko Takabayashi, Fumihiko Ando, Kei Ikeda, et al.
Current Medical Research and Opinion|March 9, 2022
Current status of shared decision making for rheumatoid arthritis treatment in Japan: a web-based survey on physicians and patientsHiroto Tsuboi, Yuko Kaneko, Kei Ikeda, et al.
International Archives of Allergy and Immunology|June 11, 2005
Stat5a is essential for the proliferation and survival of murine mast cellsKei Ikeda, Hiroshi Nakajima, Kotaro Suzuki, et al.
Modern Rheumatology|April 12, 2022
Antiphospholipid antibody positivity and the thrombotic risk in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitisJunya Suzuki, Shunsuke Furuta, Takahiro Sugiyama, et al.
Modern Rheumatology|December 15, 2021
Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world studyKatsuhiko Takabayashi, Fumihiko Ando, Kei Ikeda, et al.
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Human Cell|June 23, 2022
Central nervous system stimulants promote nerve cell death under continuous hypoxiaKei Ikeda-Murakami, Tomoya Ikeda, Miho Watanabe, et al.
RSC Advances|July 22, 2022
Density functional theory analysis for H<sub>2</sub>S adsorption on pyridinic N- and oxidized N-doped graphenesTakaya Fujisaki, Kei Ikeda, Aleksandar Tsekov Staykov, et al.
International Journal of Molecular Sciences|February 15, 2022
Central Nervous System Stimulants Limit Caffeine Transport at the Blood-Cerebrospinal Fluid BarrierKei Ikeda-Murakami, Naoto Tani, Tomoya Ikeda, et al.
Modern Rheumatology|November 11, 2014
A long-term follow-up of Japanese mother and her daughter with Blau syndrome: Effective treatment of anti-TNF inhibitors and useful diagnostic tool of joint ultrasound examinationYoshikazu Otsubo, Ikuo Okafuji, Toshimasa Shimizu, et al.
International Journal of Rheumatic Diseases|August 7, 2023
Treatment pattern and changes in oral glucocorticoid dose after tocilizumab treatment in patients with adult Still's disease: An analysis of a Japanese claims databaseYuko Kaneko, Hideto Kameda, Kei Ikeda, et al.
Modern Rheumatology|October 29, 2022
Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: A population-based retrospective cohort studyKatsuhiko Takabayashi, Fumihiko Ando, Kei Ikeda, et al.
Current Medical Research and Opinion|March 9, 2022
Current status of shared decision making for rheumatoid arthritis treatment in Japan: a web-based survey on physicians and patientsHiroto Tsuboi, Yuko Kaneko, Kei Ikeda, et al.
International Archives of Allergy and Immunology|June 11, 2005
Stat5a is essential for the proliferation and survival of murine mast cellsKei Ikeda, Hiroshi Nakajima, Kotaro Suzuki, et al.
Modern Rheumatology|April 12, 2022
Antiphospholipid antibody positivity and the thrombotic risk in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitisJunya Suzuki, Shunsuke Furuta, Takahiro Sugiyama, et al.
Modern Rheumatology|December 15, 2021
Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world studyKatsuhiko Takabayashi, Fumihiko Ando, Kei Ikeda, et al.
Pageof 17